Status:

COMPLETED

Menstrual Cycle Study

Lead Sponsor:

Fitbit LLC

Conditions:

Menstruation

Ovulation

Eligibility:

FEMALE

18-42 years

Brief Summary

A data collection study to develop algorithms to estimate menstrual cycle phases.

Eligibility Criteria

Inclusion

  • Inclusion:
  • Adults who are between 18 - 42 years old at enrollment and menstruate
  • Capable of giving informed consent in Spanish or English
  • Menstrual cycle lengths between 21- 45 days
  • Have tracked menstruation for at least 3 menstrual cycles out of the prior 6 months
  • Willing to wear a wrist-worn wearable device continuously for 6 months
  • Willing to use an ovulation predictor kit for 6 months
  • Willing to report vaccine history
  • Owns a smartphone compatible with the study and has access to wi-fi
  • Exclusion:
  • A citizen of the European Union or United Kingdom
  • Trying to conceive during the six-month study period
  • Have used specific forms of birth control in the 3 months prior to the study or planning on using specific birth control methods during the study duration
  • Participant has undergone hormonal treatment in the past 3 months or planning to do so during the study
  • Known history of health-related issues that affect their menstrual cycle, history of pelvic radiation, vasomotor symptoms, endometriosis, fibroids, polyps, ovarian cysts or known history of health-related issues that affect the physiology
  • Currently (or within the past 3 months) engaged in health impacting behaviors
  • Have been breastfeeding or pregnant in the past 6 months prior to the study
  • On medications or taking substances that could affect their menstrual cycle or physiology
  • Travel frequently such as crossing more than two time zones at least once every 2 weeks
  • Have a known sleeping disorder or consistently work night shifts

Exclusion

    Key Trial Info

    Start Date :

    July 25 2023

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    August 30 2024

    Estimated Enrollment :

    143 Patients enrolled

    Trial Details

    Trial ID

    NCT05999123

    Start Date

    July 25 2023

    End Date

    August 30 2024

    Last Update

    December 20 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Artemis Headlands LLC (Artemis Institute for Clinical Research)

    San Diego, California, United States, 92103